Corona cases are again increasing in the country, in such a situation it is necessary to have the vaccine available soon. There is news of relief on the Corona vaccine that the country will get the first lot of vaccine in late January or early February. While four pharmaceutical companies in India are in the second or third phase of clinical trials, Prime Minister Narendra Modi can discuss vaccine distribution with the Chief Ministers of the state on Tuesday.

Let us know that Corona cases are increasing in the country. The total cases of corona across the country have gone beyond 90 lakh, in which more than 85 lakh patients have recovered and gone to their homes. Talking about active cases, around four and a half lakh cases are active in the country.

India will soon get a vaccine
The first batch of Corona vaccine in the country may come by the end of January or the beginning of February. This vaccine will be given to first frontline workers such as doctors, nurses, municipal workers. The Central Government may approve the emergency use of the Oxford-AstraZeneca vaccine by the Serum Institute.

The Government of India will also approve SII for this vaccine as soon as it is approved in the United Kingdom. According to an official source, the government of India will buy the vaccine in large quantities, so the price agreement has been done by the government. 500-600 rupees will have to be paid for a two-shot vaccine.

Prime Minister Modi’s meeting regarding vaccine distribution
On Tuesday, Prime Minister Narendra Modi can hold a virtual meeting, in this meeting will be the Chief Minister of all states and union territories. The status of Covid-19 in the states will be reviewed at the meeting. The four vaccine companies in the country are in the second or third phase of clinical trials, so there may be a discussion on vaccine delivery in the meeting.

Prime Minister Narendra Modi can hold one to two meetings on Tuesday. The first meeting will include the chief ministers or representatives of the states where Corona currently has the highest number of cases.

The vaccine task force will soon meet in the country to review the vaccine’s scientific status and decide whether India should think of emergency authority. The Serum Institute, which is making the Oxford-AstraZeneca vaccine, will apply for emergency authorization in India. Serum Institute will do this as soon as it is approved in the United Kingdom.